Publications by authors named "Anthony W H Chan"

This study investigates the synergistic antitumor effect of PEG-BCT-100, an arginase, in clinical trials, with canavanine in pancreatic cancer, in vitro and in vivo. The treatment induces cancer cell apoptosis while sparing normal fibroblasts. Our findings suggest heightened susceptibility of pancreatic tumors deficient in arginine biosynthesis enzymes ASS1 and OTC.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how hepatocellular carcinoma (HCC) adapts to resistance against anti-PD-L1 immunotherapies, revealing the importance of tumour microenvironment remodelling.
  • Researchers created resistant HCC models and used advanced techniques like single-cell RNA sequencing to explore the mechanisms of resistance, finding that certain immune cells (MDSCs) grow alongside tumours and suppress the immune response.
  • The research identified a specific pathway involving PPARγ, which enhances VEGF-A production, leading to immune dysfunction and poor patient outcomes, suggesting that targeting this pathway could potentially enhance the effectiveness of immunotherapies.
View Article and Find Full Text PDF

Background: Liver fibrosis is characterized by macromolecule depositions. Recently, a novel technology termed macromolecular proton fraction quantification based on spin-lock magnetic resonance imaging (MPF-SL) is reported to measure macromolecule levels.

Hypothesis: MPF-SL can detect early-stage liver fibrosis by measuring macromolecule levels in the liver.

View Article and Find Full Text PDF

Obesity is a major risk factor for cancers including hepatocellular carcinoma (HCC) that develops from a background of non-alcoholic fatty liver disease (NAFLD). Hypercholesterolemia is a common comorbidity of obesity. Although cholesterol biosynthesis mainly occurs in the liver, its role in HCC development of obese people remains obscure.

View Article and Find Full Text PDF

Immune evasion is indispensable for cancer initiation and progression, although its underlying mechanisms in pancreatic ductal adenocarcinoma (PDAC) are not fully known. Here, we characterize the function of tumor-derived PGRN in promoting immune evasion in primary PDAC. Tumor- but not macrophage-derived PGRN is associated with poor overall survival in PDAC.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how genetic variants influence non-alcoholic fatty liver disease (NAFLD) across different body weight categories (lean, overweight, obese) in the Asian population.
  • Analyzing 904 participants, the results show that 12.4% of lean, 41.4% of overweight, and 59.1% of obese individuals have NAFLD, with lean individuals more likely to carry the PNPLA3 GG genotype, which significantly increases NAFLD risk.
  • The findings suggest that genetic risk factors, specifically the PNPLA3 variant, have a stronger impact on liver fat accumulation in lean individuals compared to those who are overweight or obese.
View Article and Find Full Text PDF
Article Synopsis
  • A high-fat diet (HFD) has been linked to an increased risk of colorectal cancer (CRC), affecting gut microbiota and metabolites in mouse models.
  • Mice on an HFD exhibited higher tumor formation, altered gut microbiota with an increase in harmful bacteria, and compromised gut barrier function compared to those on a control diet.
  • The study suggests that the changes caused by an HFD, including shifts in gut microbiota and metabolite levels (like elevated lysophosphatidic acid), play a crucial role in driving the development of CRC.
View Article and Find Full Text PDF

Background: Pegylated recombinant human arginase (PEG-BCT-100) is an arginine depleting drug. Preclinical studies showed that HCC is reliant on exogenous arginine for growth due to the under-expression of the arginine regenerating enzymes argininosuccinate synthetase (ASS) and ornithine transcarbamylase (OTC).

Methods: This is a single arm open-label Phase II trial to assess the potential clinical efficacy of PEG-BCT-100 in chemo naïve sorafenib-failure HCC patients.

View Article and Find Full Text PDF

Background & Aims: Immune checkpoint blockade (ICB) has been approved for treatment of hepatocellular carcinoma (HCC). However, many patients with advanced HCC are non-responders to ICB monotherapy. Cytotoxic chemotherapy has been proposed to modulate the tumor microenvironment (TME) and sensitize tumors to ICB.

View Article and Find Full Text PDF

Background: Clofazimine (CFZ), a riminophenazine, is now commonly used in the treatment of multidrug-resistant tuberculosis. However, its use may be potentially associated with cardiac dysfunction in some individuals. In this study, the zebrafish heart, by merit of its developmental and genetic characteristics being in homology with that of human, was chosen as an animal model for evaluation of such dysfunction.

View Article and Find Full Text PDF

Expression of ATP-binding cassette B5 (ABCB5) has been demonstrated to confer chemoresistance, enhance cancer stem cell properties and associate with poor prognosis in hepatocellular carcinoma (HCC). The aim of this study was to evaluate the genetic variations of ABCB5 in HCC patients with reference to healthy individuals and the clinicopathological significance. A pilot study has examined 20 out of 300 pairs HCC and paralleled blood samples using conventional sequencing method to cover all exons and exon/intron regions to investigate whether there will be novel variant sequence and mutation event.

View Article and Find Full Text PDF
Article Synopsis
  • Non-alcoholic fatty liver disease (NAFLD) is linked to increased rates of hepatocellular carcinoma (HCC), with the study focusing on how dietary cholesterol affects its progression through changes in gut microbiota.
  • Mice were fed different diets for 14 months, revealing that a high-fat/high-cholesterol diet led to severe liver disease stages, including steatosis and HCC, associated with gut microbiota imbalances.
  • The study concluded that dietary cholesterol alters gut bacteria and their metabolites, contributing to liver disease, but this effect can be mitigated by cholesterol-lowering medications like atorvastatin.
View Article and Find Full Text PDF

A 56-year-old man presented with an 11-cm hepatocellular carcinoma (HCC) at segment 7 of liver. To induce left liver hypertrophy, a sequential transarterial chemoembolization (TACE) and portal vein embolization before right hepatectomy were adopted. However, the tumor further increased in size despite TACE and invaded through the diaphragm to the right lung base.

View Article and Find Full Text PDF

Background: The use of macroscopic on-site evaluation (MOSE) to estimate the adequacy of a specimen for histological diagnosis during endoscopic ultrasound (EUS)-guided fine-needle tissue acquisition (FNTA) has recently been advocated. This study aimed to evaluate the diagnostic yield of MOSE compared with conventional EUS-FNTA without rapid on-site evaluation (ROSE).

Methods: This was an international, multicenter, prospective, randomized controlled study.

View Article and Find Full Text PDF

Background & Aims: Intratumor heterogeneity and divergent clonal lineages within and among primary and recurrent hepatocellular carcinomas (HCCs) produce challenges to patient management. We investigated genetic and epigenetic variations within liver tumors, among hepatic lesions, and between primary and relapsing tumors.

Methods: Tumor and matched nontumor liver specimens were collected from 113 patients who underwent partial hepatectomy for primary or recurrent HCC at 2 hospitals in Hong Kong.

View Article and Find Full Text PDF

The 2019 novel coronavirus disease (COVID-19) epidemic originated in Wuhan, China and spread rapidly worldwide, leading the World Health Organization to declare an official global COVID-19 pandemic in March 2020. In Hong Kong, clinicians and other healthcare personnel collaborated closely to combat the outbreak of COVID-19 and minimize the cross-transmission of disease among hospital staff members. In the field of otorhinolaryngology-head and neck surgery (OHNS) and its various subspecialties, contingency plans were required for patient bookings in outpatient clinics, surgeries in operating rooms, protocols in wards and other services.

View Article and Find Full Text PDF

Background & Aims: Alterations in the intestinal microbiota affect development of colorectal cancer and drug metabolism. We studied whether the intestinal microbiota affect the ability of aspirin to reduce colon tumor development in mice.

Methods: We performed studies with APC mice and mice given azoxymethane and dextran sulfate sodium to induce colorectal carcinogenesis.

View Article and Find Full Text PDF

Serrated polyps are a clinically and molecularly heterogeneous group of lesions that can contribute to the development of colorectal cancers (CRCs). However, the molecular mechanism underlying the development of serrated lesions is still not well understood. Here, we combined multiple approaches to analyze the genetic alterations in 86 colorectal adenomas (including 35 sessile serrated lesions, 15 traditional adenomas, and 36 conventional adenomatous polyps).

View Article and Find Full Text PDF

Background: With the continuous development of new antibodies, the use of immunohistochemistry (IHC) is becoming more often a requirement. IHC is frequently necessary for establishing cancer diagnosis and making therapeutic decisions. However, cytology specimens such as effusion fluid and fine-needle aspiration are highly variable in cellularity and contain background inflammatory and mesothelial cells.

View Article and Find Full Text PDF

Colorectal cancer (CRC) is a kind of solid tumor and the third most common cancer type in the world. It is a heterogeneous disease characterized by genetic and epigenetic aberrations. The mutation is the key step driving the transition from adenoma to adenocarcinoma.

View Article and Find Full Text PDF

Background And Aims: The heterogeneity of intermediate-stage hepatocellular carcinoma (HCC) and the widespread use of transarterial chemoembolization (TACE) outside recommended guidelines have encouraged the development of scoring systems that predict patient survival. The aim of this study was to build and validate statistical models that offer individualized patient survival prediction using response to TACE as a variable.

Approach And Results: Clinically relevant baseline parameters were collected for 4,621 patients with HCC treated with TACE at 19 centers in 11 countries.

View Article and Find Full Text PDF

Background & Aims: Intratumor heterogeneity and divergent clonal lineages within and among primary and recurrent hepatocellular carcinomas (HCCs) produce challenges to patient management. We investigated genetic and epigenetic variations within liver tumors, among hepatic lesions, and between primary and relapsing tumors.

Methods: Tumor and matched nontumor liver specimens were collected from 113 patients who underwent partial hepatectomy for primary or recurrent HCC at 2 hospitals in Hong Kong.

View Article and Find Full Text PDF
Article Synopsis
  • * P. anaerobius adheres to the CRC mucosa and activates signaling pathways in CRC cells via a surface protein called PCWBR2, which interacts with the α/β integrin receptor, leading to increased cell proliferation and an inflammatory response.
  • * The study identifies the PCWBR2-integrin α/β signaling pathway as a potential therapeutic target to inhibit the oncogenic effects of P. anaerobius in CRC development.
View Article and Find Full Text PDF

Different clones, protocol conditions, instruments, and scoring/readout methods may pose challenges in introducing different PD-L1 assays for immunotherapy. The diagnostic accuracy of using different PD-L1 assays interchangeably for various purposes is unknown. The primary objective of this meta-analysis was to address PD-L1 assay interchangeability based on assay diagnostic accuracy for established clinical uses/purposes.

View Article and Find Full Text PDF